Sandra M Lord

4PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersMolecular targetsOptical technologyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 07, 2024
Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes.

Stephan Pribitzer, Colin O'Rourke, Alyssa Ylescupidez

|Dec 14, 2023
Testing a new platform to screen disease-modifying therapy in type 1 diabetes.

Sandra M Lord, Henry T Bahnson, Carla J Greenbaum

|Aug 12, 2023
OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive Individuals.

Alyssa Ylescupidez, Cate Speake, Susan L Pietropaolo

|Mar 15, 2022
Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.

Yevgeniy Yuzefpolskiy, Peter Morawski, Mitch Fahning

Pageof 1

Frequent Collaborators

4 joint publications

Cate Speake

1 joint publications

Yevgeniy Yuzefpolskiy

1 joint publications

Peter Morawski

1 joint publications

Mitch Fahning